Exc f/e/e/n/l mal+mrg 1.1-2
CPT 11642 is used when a physician surgically removes a cancerous or potentially cancerous skin lesion (including melanoma) from the face, ears, eyelids, nose, or lips that measures between 1.1 and 2.0 centimeters, plus a margin of healthy tissue around it.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Accurately measure and document the excised diameter (lesion plus margins) not just the clinical lesion size; the excised diameter determines code selection and 11642 requires 1.1-2.0 cm total
Impact: Incorrect measurement documentation causes up to 40% of denials; upcoding from 11641 (≤1.0 cm, $192.58) to 11642 ($260.39) requires clear documentation of excised diameter, representing $67.81 difference
Bill in non-facility settings when possible to capture the $83.13 differential between non-facility ($260.39) and facility ($177.26) rates
Impact: Office-based procedures yield 47% higher reimbursement than hospital outpatient settings; annual volume of 100 cases represents $8,313 additional revenue
Obtain and reference pathology confirmation of malignancy with specific ICD-10 diagnosis codes; never bill excision of malignant lesion codes without pathologic diagnosis or strong clinical suspicion documented
Impact: Billing 11642 without confirmed or suspected malignancy results in 90%+ denial rate; use 11442 (excision benign lesion) if no malignancy suspected, which reimburses at $225.87, avoiding potential fraud allegations
Document anatomical location with specificity (which facial subunit, which part of ear, upper vs lower eyelid) as excisions from face/ears/eyelids/nose/lips reimburse higher than trunk/extremities
Impact: 11642 (face/ears/eyelids/nose/lips) pays $260.39 vs 11602 (trunk/arms/legs 1.1-2.0 cm) at $189.26, a $71.13 difference per procedure; vague location documentation risks downcoding
For multiple excisions, list procedures in descending RVU order with highest-value procedure first (no modifier) and apply modifier 51 to subsequent procedures
Impact: Proper sequencing maximizes reimbursement under multiple procedure payment reduction rules; incorrect ordering can result in 5-10% lost revenue across all procedures
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.